CESCA THERAPEUTICS I...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
CESCA THERAPEUTICS INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees (as per )no data available
Sector Medical Devices, HealthcareMedical Devices, Healthcareno data available
Ticker KOOLno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 172,53,03,54,04,5
datesClosing price (adj.)
13.10.20173.97
11.10.20174.30
04.10.20174.41
27.09.20173.55
20.09.20173.50
13.09.20173.30
06.09.20173.26
30.08.20173.38
23.08.20173.28
16.08.20173.37
09.08.20173.38
02.08.20173.57
26.07.20173.62
19.07.20173.70
12.07.20173.47
05.07.20173.14
27.06.20173.09
20.06.20173.03
13.06.20173.05
06.06.20173.06
30.05.20173.10
23.05.20173.11
16.05.20173.12
09.05.20173.14
02.05.20173.14
25.04.20173.10
18.04.20173.05
11.04.20173.27
04.04.20173.16
28.03.20173.28
21.03.20173.08
14.03.20172.87
07.03.20172.75
28.02.20172.99
21.02.20172.95
14.02.20172.98
07.02.20172.97
31.01.20172.99
24.01.20172.90
17.01.20173.04
10.01.20173.22
03.01.20173.30
27.12.20162.67
19.12.20162.78
12.12.20162.98
05.12.20163.11
28.11.20162.93
21.11.20162.99
14.11.20162.96
07.11.20163.02
31.10.20163.01
24.10.20163.90
17.10.20163.06
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 3.97n/a
Market Capitalisation
in million USD
 39n/a
Enterprise Value
in million USD
 33n/a
Common Shares Outstanding
as per Sep 30, 2016
 9,790,500n/a
Preferred Shares Outstanding
as per Sep 30, 2016
 n/a
Average Basic Shares Outstanding
TTM
 -6,170,267n/a
Average Diluted Shares Outstanding
TTM
 n/a
Index Membership
n/a
Business Summary
Cesca Therapeutics Inc is engaged in the development and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 6n/a
Receivables 3n/a
Total Current Assets 12n/a
PP&E 3n/a
Total Assets 49n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 4n/a
Long-Term Debt 0n/a
Total Liabilities 13n/a
Total Equity 36n/a
Cash Flow
Depreciation & Amortisation 1n/a
Change in Working Capital -3n/a
Operating Cash Flow -10n/a
Net Change in PP&E and Intangibles -1n/a
Investing Cash Flow -1n/a
Dividends Paid 0n/a
Financing Cash Flow 10n/a
Total Change in Cash -1n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share -5.89n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value -0.67n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.93n/a
Other Ratios
Current Ratio 308.6%n/a
Liabilities to Equity Ratio 35.4%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 64% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
23
23
19
18
16
16
12
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
-16
-15
-13
-12
-10
-11
-9
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
7
9
6
6
6
5
3
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-13
-12
-12
-12
-15
-20
-14
Selling, General & Administrative
-8
-9
-8
-9
-11
-14
-10
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-5
-3
-4
-3
-3
-6
-3
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-5
-3
-5
-5
-9
-15
-11
Non-Operating Income (Loss)
0
0
0
0
0
0
2
Interest Expense, net
0
0
0
0
0
0
2
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-5
-3
-5
-5
-9
-15
-9
Abnormal Gains (Losses)
0
0
0
2
0
0
-2
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-5
-3
-5
-3
-9
-15
-11
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-5
-3
-5
-3
-9
-15
-11
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-5
-3
-5
-3
-9
-15
-11
Minority Interest
0
0
0
0
0
0
0
Net Income
-5
-3
-5
-3
-9
-15
-11
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-5
-3
-5
-3
-9
-15
-11
Remarks
restated on Sep 21, 2012 n/a
calculated values,
restated on Sep 4, 2013 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Sep 17, 2015 n/a
calculated values,
restated on Sep 21, 2016 n/a
calculated values,
restated on Sep 21, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
12
8
7
15
3
6
Cash & Cash Equivalents
n/a
12
8
7
15
3
6
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
4
5
5
5
5
3
Accounts Receivable, Net
n/a
4
5
5
5
5
3
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
6
6
4
6
5
4
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
0
0
0
0
0
0
Prepaid Expenses
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
Total Current Assets
n/a
23
19
16
25
13
13
Property, Plant & Equipment, Net
n/a
1
2
2
2
3
3
Property, Plant & Equipment
n/a
1
2
2
2
3
3
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
0
0
0
35
35
34
Intangible Assets
n/a
0
0
0
22
21
21
Goodwill
n/a
0
0
0
13
13
13
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
0
0
0
0
0
0
Total Noncurrent Assets
n/a
1
2
2
38
38
37
Total Assets
n/a
24
21
19
63
51
50
Liabilities and owners' equity
Payables & Accruals
n/a
2 2175000
3 3379000
4 3583000
4 4189000
6 5784000
3 3097000
Accounts Payable
n/a
2 1791000
3 2772000
3 3106000
4 3590000
5 5079000
3 2648000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 384000
1 607000
0 477000
1 599000
1 705000
0 449000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
2 1889000
2 1652000
2 1565000
2 2191000
2 2162000
2 2445000
Deferred Revenue
n/a
0 235000
0 424000
0 377000
1 638000
1 635000
1 783000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
2 1654000
1 1228000
1 1188000
2 1553000
2 1527000
2 1662000
Total Current Liabilities
n/a
4 4064000
5 5031000
5 5148000
6 6380000
8 7946000
6 5542000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
2 2489000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
0 242000
0 151000
0 63000
8 7810000
8 7909000
10 9595000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 242000
0 55000
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
8 7641000
8 7641000
8 7641000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
1 670000
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 96000
0 63000
0 169000
0 268000
1 1284000
Total Noncurrent Liabilities
n/a
0 242000
0 151000
0 63000
8 7810000
8 7909000
12 12084000
Total Liabilities
n/a
4 4306000
5 5182000
5 5211000
14 14190000
16 15855000
18 17626000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
126 126212000
127 127003000
128 127509000
171 171462000
173 172581000
189 188572000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-106 -106119000
-111 -111105000
-114 -114191000
-123 -122822000
-138 -137674000
-156 -156262000
Other Equity
n/a
0 0
0 0
0 0
0 58000
0 -5000
0 -37000
Equity Before Minority Interest
n/a
20 20093000
16 15898000
13 13318000
49 48698000
35 34902000
32 32273000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
20 20093000
16 15898000
13 13318000
49 48698000
35 34902000
32 32273000
Total Liabilities & Equity
n/a
24 24399000
21 21080000
19 18529000
63 62888000
51 50757000
50 49899000
Remarks restated on n/a restated on Sep 21, 2012 n/a restated on Sep 4, 2013 n/a restated on Sep 29, 2014 n/a restated on Sep 17, 2015 n/a restated on Sep 21, 2016 n/a restated on Nov 17, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-5
-3
-5
-3
-9
-15
-19
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
1
1
1
1
1
Non-Cash Items
1
1
1
-1
0
2
8
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
0
-1
0
1
0
1
0
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-4
-2
-4
-3
-8
-11
-10
Change in Fixed Assets & Intangibles
0
0
-1
0
0
-1
-1
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
-7
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
3
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
16
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
9
0
-1
2
0
-1
-1
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
11
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
0
4
0
0
16
0
2
Increase in Capital Stock
0
4
0
0
16
0
2
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
-1
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
0
4
0
0
16
0
13
Net Cash Before Disc. Operations and FX
4
2
-4
-1
8
-11
2
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
4
2
-4
-1
8
-11
2
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
4
2
-4
-1
8
-11
2
Remarks
restated on Sep 21, 2012 n/a
calculated values,
restated on Sep 4, 2013 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Sep 29, 2014 n/a
calculated values,
restated on Sep 17, 2015 n/a
calculated values,
restated on Sep 21, 2016 n/a
calculated values,
restated on Sep 21, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo